Inpatient and Outpatient Orderable

Hepatitis C Virus (HCV) Antibody with Reflex to Qualitative Molecular Detection Build info

Synonyms

  • HEPATITIS C ANTIBODY
  • HEPATITIS C ANTIBODY TEST
  • HEPATITIS C AB W/REFLEX TO QUALITATIVE HCVRNA
  • ANTI-HCV
  • HEPC
  • HCVAB
  • LAB868

Procedure Name

HEPATITIS C ANTIBODY

Procedure Master Number

LAB868

Cerner Name

Hepatitis C AB

Procedure ID

64768

Clinical Info

This is a testing algorithm for the diagnosis of HCV infection. Positive antibody results will reflex to confirmation by molecular detection.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: Gold-top tube(s)
1.0 mL serum
Allow 30 minutes to clot after collection
Transport Temperature: Refrigerate

Specimen Volume

1.0 mL serum

Transport Instructions

Refrigerate

Specimen Stability

Core Laboratory
3 Days Room Temperature
7 Days Refrigerated
NSUH
3 Days Room Temperature
21 days refrigerated
3 months frozen -15 to -25C

Methodology

Immunoassay 

Days Performed

Monday through Saturday

Performing Laboratory

Northwell Health Laboratories

CPT

86803

PDM

 5302685

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
HEPATITIS C HEPC HEPATITIS C Hepatitis C Antibody
HEPATITIS C VIRUS S/CO RATIO HEPCRATIO HEP C RATIO HCV S/CO Ratio
HEPATITIS C VIRUS INTERPRETATION HEPCINTERP HEP C INTERP HCV Interpretation

Result Interpretation

Northwell Core Laboratory (Outpatients)

S/CO Ratio                       Interpretation

0.00 – 0.79                         Non-Reactive

0.80 – 0.99                         Equivocal

> 1.00                                Reactive

Non-Reactive: Antibodies to HCV were not detected; does not exclude the possibility of recent exposure to HCV. No further action is needed unless recent infection is expected.

Equivocal: Antibodies to HCV may or may not be present. HCV RNA testing will follow to identify current infection.

Reactive: Presumptive evidence of antibodies to HCV. HCV RNA testing will follow to identify current infection.

***

North Shore University Hospital (Inpatient)

Cutoff Index (COI)                      Interpretation

≤0.89                                                Non-Reactive

0.90 ≤ COI < 1.00                             Border

> 1.00                                               Reactive

Border results are retested in duplicate (2 of 3 results) to resolve final results.

Non-Reactive: Antibodies to HCV were not detected; does not exclude the possibility of recent exposure to HCV. No further action is needed unless recent infection is expected.
 
Reactive: Presumptive evidence of antibodies to HCV. HCV RNA testing will follow to identify current infection.
 
Note: HCV antibody testing is performed on the Roche e602 analyzer.
 

Forms
edit